Healios KK
6VX
Company Profile
Business description
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.
Contact
World Trade Center Bldg. 15th Floor
2-4-1 Hamamatsucho
Minato-ku
Tokyo105-6115
JPNSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,158.70 | 9.80 | 0.12% |
| CAC 40 | 8,035.24 | 58.96 | -0.73% |
| DAX 40 | 22,827.56 | 171.59 | -0.75% |
| Dow JONES (US) | 41,710.11 | 243.21 | -0.58% |
| FTSE 100 | 8,644.75 | 57.24 | -0.66% |
| HKSE | 23,689.72 | 530.23 | -2.19% |
| NASDAQ | 17,581.01 | 110.61 | -0.63% |
| Nikkei 225 | 37,677.06 | 74.82 | -0.20% |
| NZX 50 Index | 12,113.54 | 58.82 | 0.49% |
| S&P 500 | 5,623.46 | 39.43 | -0.70% |
| S&P/ASX 200 | 7,931.20 | 12.30 | 0.16% |
| SSE Composite Index | 3,364.83 | 44.12 | -1.29% |